bioMérieux S.A.
PAR: BIM.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Pierre Boulud
- Employees
- 14,147
- Headquarters
- Marcy l'Étoile, France
- IPO year
- 2004
- Market cap
- €8.4B
- Website
- https://www.biomerieux.com
Loading BIM…
Loading profile data…Frequently asked questions about BIM
What does bioMérieux S.A. (BIM.PA) do?
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing...
Where does BIM.PA trade?
bioMérieux S.A. (BIM.PA) trades on the Euronext Paris.
What sector is BIM.PA in?
bioMérieux S.A. (BIM.PA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of bioMérieux S.A.?
Pierre Boulud is the chief executive officer of bioMérieux S.A. (BIM.PA).
Where is bioMérieux S.A. headquartered?
bioMérieux S.A. is headquartered in France.
Does BIM.PA pay a dividend?
Yes — bioMérieux S.A. (BIM.PA) paid a trailing twelve-month dividend of EUR 0.90 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BIM.PA go public?
bioMérieux S.A. (BIM.PA) completed its initial public offering in 2004.